In June 2025, the global market of Nicotinamide has rebounded as suppliers strategically corrected prices after following a sharp declining trend in May. The increase was driven by supplier-led interventions to stabilize the market sentiment and prevent any further downtrend. There were no disruptions in production or policy changes in June of 2025. The steady downstream demand from pharmaceutical, nutraceutical and fortified food & beverage sectors have supported this correction as buyers restocked their inventories ahead of new production cycles in third quarter of 2025.
The global market of Nicotinamide has witnessed a rebound in June 2025 after experiencing a price slump in May. The suppliers across key markets have initiated a calculated price correction to arrest further decline in market. This price recovery has reflected a well-planned supplier strategy...
Selenis has effectively manufactured recycled PET chips using terephthalic acid sourced from Circ®, a textile-to-textile recycler based in Virginia. The chip production took place through a series of batches at Selenis' pilot plant in San-Giorgio, Italy. By utilizing inputs recovered from polycotton textile waste, Selenis has created high-quality PET chip, which has been further processed into DTY yarn. This yarn will play a crucial role in product development as Circ prepares for additional capsule launches. Selenis is leveraging the success of this initial collaboration phase and is committed to advancing towards an offtake partnership to support Circ's inaugural industrial facility.
Eduardo Santos, Head of Corporate Strategy at Selenis, remarked that the monomer synthesis showed a performance comparable to virgin terephthalic acid. He expressed optimism about the consistent quality of Circ's monomer output and anticipated future commercial success. Santos pointed out that the Circ partnership complements Selenis's existing mission and goals for a more sustainable textile industry. He further stated their anticipation of expanding upon this collaboration and providing support for Circ's forthcoming commercial production trials.
